Fifth Third Bancorp Has $554,000 Position in The Clorox Company $CLX

Fifth Third Bancorp lowered its stake in shares of The Clorox Company (NYSE:CLX) by 3.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,613 shares of the company’s stock after selling 165 shares during the period. Fifth Third Bancorp’s holdings in Clorox were worth $554,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CLX. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Clorox by 7.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 49,141 shares of the company’s stock valued at $7,981,000 after buying an additional 3,364 shares during the period. Wellington Management Group LLP boosted its holdings in Clorox by 18.8% in the fourth quarter. Wellington Management Group LLP now owns 4,074 shares of the company’s stock worth $662,000 after purchasing an additional 646 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Clorox by 11,108.0% in the first quarter. GAMMA Investing LLC now owns 349,130 shares of the company’s stock worth $51,409,000 after purchasing an additional 346,015 shares in the last quarter. Fifth Third Wealth Advisors LLC boosted its holdings in Clorox by 36.4% in the first quarter. Fifth Third Wealth Advisors LLC now owns 1,712 shares of the company’s stock worth $252,000 after purchasing an additional 457 shares in the last quarter. Finally, Rhumbline Advisers increased its holdings in shares of Clorox by 5.7% during the 1st quarter. Rhumbline Advisers now owns 273,462 shares of the company’s stock valued at $40,267,000 after acquiring an additional 14,647 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.57% of the company’s stock.

Clorox Price Performance

Shares of Clorox stock opened at $122.95 on Tuesday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market capitalization of $15.04 billion, a price-to-earnings ratio of 18.86, a P/E/G ratio of 1.00 and a beta of 0.52. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The firm’s 50-day moving average price is $123.46 and its two-hundred day moving average price is $130.06.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same period in the prior year, the business earned $1.82 earnings per share. Clorox’s quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. Clorox’s dividend payout ratio (DPR) is 76.07%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CLX. Barclays cut their target price on shares of Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a research report on Tuesday, July 15th. Wells Fargo & Company cut their target price on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a research report on Monday, September 8th. Morgan Stanley cut their target price on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research report on Friday, August 1st. Finally, Citigroup reissued a “neutral” rating and set a $135.00 target price (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus target price of $141.73.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.